This week’s EU health policy developments range from cancer prevention and tobacco control to medical device reform, pesticide regulation, and healthcare workforce resilience. The Commission confirmed plans to revise the Medical Devices Regulation by end-2025, detailed actions on e-cigarettes and vector-borne diseases, and addressed chemical safety, cross-border health risks, and emergency access in an evolving digital and environmental landscape.
This week’s EU health policy developments range from new mental health initiatives and the Pfizergate transparency case to waste disposal risks, Green Deal health impacts, and Mercosur trade concerns — all based on verified institutional sources.
Overview This report summarises key Parliamentary Questions (PQs) submitted during the June – July 2025 period. […]
This week’s EU health policy developments range from workforce pressures and medicine shortages to rare disease research, PFAS monitoring, and crisis preparedness. Key issues include newborn screening disparities, mental health, and data ethics in digital health and AI regulation.
This week’s EU health and governance developments range from healthcare access and ME/CFS research to glyphosate safety, burnout prevention, and humanitarian issues in Gaza. The Commission’s replies highlight growing focus on patient rights, vaccine safety, disability inclusion, and transparency in EU governance.
This week’s EU health and regulatory developments range from youth vaping and tobacco-control reforms to food safety, cardiovascular health, and healthcare cybersecurity. The Commission also addressed glyphosate safety, NGO funding oversight, and industrial cases like the Tesla Gigafactory, underscoring a strong enforcement and transparency agenda.
This week’s EU health and policy developments range from vaccine liability, disease preparedness, and women’s health to food additives, medical device reform, and healthcare funding. The Commission reaffirmed its commitments on vaccine safety, climate resilience, data protection, and equitable access to medicines and care across Member States.
